Study ID |
Treatment, dose, frequency |
Number of adverse events |
Group total |
Percentage |
De Leo 2017 |
D‐mannose + cranberry + noxamicina (unknown doses) |
0 |
100 |
0% |
No treatment |
0 |
50 |
0% |
Kranjcec 2014 |
D‐mannose 2 g
|
8 |
103 |
78% |
Nitrofurantoin 50 mg (antibiotic)
Diarrhoea: 10
Nausea: 6
Headache: 3
Skin rash: 1
Vaginal burning: 9
|
29 |
103 |
28% |
No treatment |
0 |
102 |
0% |
Kuzmenko 2019 |
Not reported |
Not reported |
Not reported |
Not reported |
Lopes de Carvalho 2012 |
D‐mannose 100 mg + cranberry 40 mg + vitamin C 60 mg |
Not reported |
Not reported |
Not reported |
Placebo |
Not reported |
Not reported |
Not reported |
Palleschi 2017 |
D‐mannose 500 mg + N‐acetylcysteine 100 mg + Morinda citrifolia fruit extract 300 mg |
0 |
37 |
0% |
Prulifloxacin 400 mg (antibiotic) |
0 |
38 |
0% |
Porru 2014 |
D‐mannose 1 g |
Not reported |
Not reported |
Not reported |
Trimethoprim 160 mg + sulfamethoxazole 800 mg (antibiotics) |
Not reported |
Not reported |
Not reported |
Russo 2019 |
Cranberry + D‐mannose + Boswellia + Curcuma + NoxamicineVR (Kistinox ActVR ) oral preparation (doses not reported) |
0 |
20 |
0% |
No treatment |
0 |
20 |
0% |